Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.120
+0.040 (0.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $177.87 million as of November 21, 2024.
Market Cap
177.87M
Enterprise Value
-134.58M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $177.87M, a decrease of -80.20%. That is a compound annual growth rate of -87.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 177.87M | -80.20% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 180.20M |
| Tenaya Therapeutics | 179.83M |
| BrainsWay | 176.99M |
| Verastem | 176.25M |
| scPharmaceuticals | 176.14M |
| Nkarta | 175.01M |
| Actuate Therapeutics | 173.83M |
| Stereotaxis | 173.70M |